(PharmaNewsWire.Com, March 06, 2017 ) According to Publisher, the Global Cell Banking Outsourcing market is expected to grow from $3.42 billion in 2015 to reach $10.67 billion by 2022 with a CAGR of 17.6%. Growing research in cell line development and advancements in cell preservation techniques are the key factors fostering the market growth. In addition, increasing awareness of stem cell therapies, growth in cell bank facilities around the world are some of the key factors influencing the market growth. On the other hand, differing legal and ethical issues among countries throughout collection of cells, and therapies costs are inhibiting the market growth.
The stem cell banking leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to growing number of cord blood banks, and services among countries. North America is anticipated to hold the largest share in global market due to increasing demand from U.S. Asia Pacific is expected to witness huge growth due to encouraging government schemes and growing adoption of cell therapies.
Some of the key players in global cell banking outsourcing market include CordLife, Cleancells, Charles River Laboratories, BSL Bioservice, BioReliance, BioOutsource/Sartorius, Covance, LifeCell International Pvt. Ltd., Goodwin Biotechnology Inc., GlobalStem Inc., Cryo-Cell International Inc., Cryobanks International India, Lonza, PX’Therapeutics SA, Wuxi Apptec, Tran-Scell Biologics Pvt. Ltd., Toxikon Corporation, Texcell, SGS Life Sciences, and Reliance Life Sciences.
Phases Covered: - Characterization - Preparation - Storage - Testing o Viral Cell Bank Safety Testing o Microbial Cell Bank Safety Testing o Gene Expression Testing o Karyology Testing o Gene Sequencing Testing
Bank Types Covered: - Master Cell Banking - Viral Cell Banking - Working Cell Banking
Cell Types Covered: - Stem Cell Banking o IPS Stem Cell Banking o Embryonic Cell Banking o Dental Stem Cell Banking o Adult Stem Cell Banking o Cord Cell Banking - Non-Stem Cell Banking
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Company Profiling 10.1 CordLife 10.2 Cleancells 10.3 Charles River Laboratories 10.4 BSL Bioservice 10.5 BioReliance 10.6 BioOutsource/Sartorius 10.7 Covance 10.8 LifeCell International Pvt. Ltd. 10.9 Goodwin Biotechnology Inc. 10.10 GlobalStem Inc. 10.11 Cryo-Cell International Inc. 10.12 Cryobanks International India 10.13 Lonza 10.14 PX’Therapeutics SA 10.15 Wuxi Apptec 10.16 Tran-Scell Biologics Pvt. Ltd. 10.17 Toxikon Corporation 10.18 Texcell 10.19 SGS Life Sciences 10.20 Reliance Life Sciences
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
